Non-Invasive Cancer Diagnostics Market would grow to USD 244.17 billion by 2030
Global Non-Invasive Cancer Diagnostics Market report endows with the company profile, product specifications, production value, manufacturer’s contact information and market shares for the company. This market analysis report will definitely help in growing sales with new thinking, new skills, and innovative programs and tools. All the data, statistics, and information gathered to generate this report has been studied and analysed with the established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. The market study conducted in Global Non-Invasive Cancer Diagnostics Market document takes into account heterogeneous markets in accord with the requirement of HEALTHCARE industry and scoop out the finest possible solutions and detailed information about the market trends.
Cancer ranks among the leading causes of mortality worldwide, with higher prevalence observed in both developed and developing markets. The continuous advancements in diagnostic testing technologies are expected to drive the growth of the industry. Healthcare professionals are increasingly prioritizing the development of efficient screening and treatment methods to combat the rising prevalence of cancer. As a result, numerous healthcare agencies and market participants are introducing various programs that promote advanced diagnostics, thereby contributing to the acceleration of market growth.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-noninvasive-cancer-diagnostics-market&Shri
Cancer is one of the top causes of death globally, with a higher incidence in developed and developing markets. The rapid technological advancements in diagnostic tests are anticipated to accelerate industry growth as healthcare professionals focus on developing effective screening and treatment solutions to check prevalence levels. Numerous healthcare agencies and market players are launching different programs promoting different advanced diagnostics, thus accelerating market growth.
Data Bridge Market Research analyses the non-invasive cancer diagnostics market growth rate in 2023-2030. The expected CAGR of the non-invasive cancer diagnostics market is around 7.20% in the mentioned forecast period. The market was valued at USD 140 billion in 2022 and would grow to USD 244.17 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Non-invasive cancer diagnostics is a procedure to identify varied cancer problems with minimal body incision, such as cancer. The procedure usually consists of numerous techniques, such as identifying genetic structure, biomarker, molecular biology change, and imaging technologies. This process does not harm the body as it is non-invasive and allows no point or cut.
“Growing number of technological advancements is bolstering the market growth”
The market is expected to experience growth during the forecast period, driven by advancements in diagnostic testing technologies. An example of this is Hologic, Inc.’s recent announcement in 2021 regarding the availability of the Genius Digital Diagnostics System in Europe. This advanced system utilizes deep learning-based artificial intelligence and innovative volumetric imaging technology to improve the detection of cervical cancer cells and pre-cancerous lesions in women. The introduction of this next-generation cervical cancer screening system is anticipated to significantly contribute to the market’s expansion.
What restraints the growth of the Global Non-Invasive Cancer Diagnostics Market?
“High costs associated will restrain the market growth”
The high costs and budget limitations faced by numerous hospitals in underdeveloped and developing countries make it challenging for them to invest in diagnostic imaging equipment. However, as the demand for diagnostic imaging rises in these regions, hospitals that are unable to afford new and advanced imaging systems turn to refurbished alternatives. This aspect acts as a constraint on the market’s growth.
Drivers
- Rising Developments of Diagnostic Testing Techniques
Technological advancements in diagnostic testing are anticipated to enhance market growth during the forecast period. For instance, in 2021, Hologic, Inc. announced commercial access to Europe’s Genius Digital Diagnostics System. The next-generation cervical cancer screening system involves deep learning-based AI and innovative volumetric imaging technology, which helps to help detect cervical cancer cells and pre-cancerous lesions in women. Thus, this is expected to boost the market growth.
- Increasing Incidence of Cancer Cases
The rise in the number of cancer cases and the increase in the senior population are the major factors leading to the growth of the cancer diagnostics market worldwide. As per GLOBOCAN, 2020, around 19.3 million new cancer cases were reported worldwide, which is expected to reach 30.2 million new cases in 2040. Around 1 out of 6 deaths occur because of cancer worldwide, as per the World Health Organization factsheet. Around 70% of deaths from cancer occur in low- and middle-income countries. Thus, this boosts the market growth
Non-Invasive Cancer Diagnostics Market Scope and Segmentation
| REPORT METRIC | DETAILS |
| Forecast Period | 2023 to 2030 |
| Base Year | 2022 |
| Historic Years | 2021 (Customizable to 2015 – 2020) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-noninvasive-cancer-diagnostics-market?Shri
Key players operating in the non-invasive cancer diagnostics market include:
- Abbott (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- QIAGEN (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Agilent Technologies, Inc. (U.S.)
- Quest Diagnostics Incorporated. (U.S.)
- Merck KGaA, (Germany)
- Hologic, Inc. (U.S.)
- BD. (U.S.)
- GSK plc. (U.K.)
- Novartis AG (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Lilly. (U.S.)
- Pfizer, Inc. (U.S.)
- Myriad Genetics, Inc. (U.S.)
Non-Invasive Cancer Diagnostics Market Scope
Type
- Lung Cancer
- Breast Cancer
- Solid Tumors
- Blood Cancer
- Ovarian Cancer
- Colorectal Cancer
- Other
Product Type
- Immunochemistry
- Clinical Microbiology
- Point of Care Test (POCT)
- Hematology
- Hemostasis)
Test Type
- Urine Test
- Imaging Test
- Computerized Tomography
- Magnetic Resonance Imaging
- Nuclear Medicine Scans
- X-ray/Mammography
- Ultrasound
- Spectroscopy
Application
- Blood
- Urine
- Saliva
End Users
- Hospital and Clinics
- Diagnostic Centers
- Ambulatory care
- Others
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-noninvasive-cancer-diagnostics-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
